Literature DB >> 16314238

Safety and efficacy of percutaneous CT-guided liver biopsy using an 18-gauge automated needle.

Loukas Thanos1, Alexandra Zormpala, Georgia Papaioannou, Katerina Malagari, Elias Brountzos, Dimitrios Kelekis.   

Abstract

BACKGROUND: Computed tomography (CT)-guided liver biopsy using large-caliber cutting needles allows the recovery of larger tissue specimens that are more suitable for establishing histological diagnosis. Yet, large-caliber needles are associated with higher rates of post-biopsy bleeding. The aim of this prospective study was to assess the efficacy and safety of the method, when all of the procedures were performed by experienced radiologists and all patients were carefully evaluated and treated, when needed, before the biopsy.
METHODS: A total of 767 consecutive patients with focal hepatic lesions underwent CT-guided liver biopsy during a 5-year period. The procedures were performed in a single center using 18-gauge automated biopsy guns with a 2-cm cutting edge by a team of experienced radiologists (>100 procedures performed by each one before the initiation of the study). Before the procedure, abnormal coagulation indices were corrected, ascites was treated and, in all cases, an adequate parenchymal cuff of normal tissue between the lesion and the capsule was retained.
RESULTS: In all cases the extracted specimens were adequate for diagnosis. No major complications (i.e., death or complications requiring surgery, chest tube, or blood transfusions) were observed. Minor complications (i.e., those not requiring medical intervention) were observed in three patients.
CONCLUSIONS: Percutaneous CT-guided liver biopsy using an 18-gauge automated needle is a safe and effective procedure. Careful pre-biopsy evaluation and treatment, when needed, and maintenance of an adequate parenchymal cuff between the lesion and the capsule contribute to the safety of the method.

Entities:  

Year:  2005        PMID: 16314238     DOI: 10.1016/j.ejim.2005.06.010

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  5 in total

1.  Percutaneous Liver Biopsy.

Authors:  Maya Gambarin-Gelwan
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-09

2.  Validation of a CT-guided intervention robot for biopsy and radiofrequency ablation: experimental study with an abdominal phantom.

Authors:  Hyung Jin Won; Namkug Kim; Guk Bae Kim; Joon Beom Seo; Hongho Kim
Journal:  Diagn Interv Radiol       Date:  2017 May-Jun       Impact factor: 2.630

3.  CT-guided procedures: an initial experience.

Authors:  Andrei Roman; Patriciu Achimas-Cadariu; Bogdan Fetica; Vlad Gata; Andrada Seicean
Journal:  Clujul Med       Date:  2018-10-30

4.  Characterization of hepatic tumors using [11C]metomidate through positron emission tomography: comparison with [11C]acetate.

Authors:  Anne Roivainen; Alexandru Naum; Heikki Nuutinen; Rauli Leino; Heimo Nurmi; Kjell Någren; Riitta Parkkola; Johanna Virtanen; Markku Kallajoki; Harry Kujari; Jari Ovaska; Peter Roberts; Marko Seppänen
Journal:  EJNMMI Res       Date:  2013-02-27       Impact factor: 3.138

5.  Computed tomography-guided percutaneous biopsy of abdominal lesions: indications, techniques, results, and complications.

Authors:  Luiz Henrique de Oliveira Schiavon; Chiang Jeng Tyng; Demian Junklaus Travesso; Rafael Dias Rocha; Ana Carolina Santana Andrade Schiavon; Almir Galvão Vieira Bitencourt
Journal:  Radiol Bras       Date:  2018 May-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.